HealthQuill US
US-based private equity and advisory investment firm KKR & Co. Inc. will pay CVC Capital Partners $400 million to acquire a majority stake in India’s HealthCare Global Enterprises Ltd. (HCG).
Health Medical Pharma

KKR to acquire majority stake in India’s HCG for $400 million

US-based private equity and advisory investment firm KKR & Co. Inc. will pay CVC Capital Partners $400 million to acquire a majority stake.

Read More
Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.
Drugs Health Medical

US regulator clears Mirum’s oral drug for reducing cholesterol deposits

Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.

Read More
The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation” due to low morale, poor funding and a legitimacy crisis, a UN official said.
Health Medical Pharma

UN humanitarian aid system facing ‘greatest test’ since creation: Relief chief

The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation”.

Read More
FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing the Anglo-Swedish firm to gain access to an anaemia drug in the world’s most populated nation.
Drugs Health Pharma

AstraZeneca Plc buys China unit of FibroGen Inc for $160 million

HQ Team February 21, 2025: FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing.

Read More
Merck & Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours, and who had prior treatment, has been “conditionally” approved by the European Commission, according to a company statement.
Drugs Health Medical

EC grants ‘conditional’ nod for Merck’s drug to treat VHL disease

HQ Team February 18, 2025: Merck and Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours and who had prior.

Read More
Billionaire Gautam Adani’s family plans to invest 60 billion rupees ($686.18 million) to set up two health campuses in the Indian cities of Mumbai and Ahmedabad in association with Mayo Clinic Global Consulting, according to a statement.
Uncategorized

Indian billionaire Adani to invest $686.2m to build 2 health campuses

Billionaire Gautam Adani’s family plans to invest 60 billion rupees ($686.18 million) to set up two health campuses in the Indian cities of.

Read More
Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to the Massachusetts-based firm.
Drugs Health Medical

Bain Capital to buy Japan’s Mitsubishi Tanabe Pharma for $3.3 billion

Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to.

Read More
Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, has given a four-point rebuttal to the US government’s accusations against the global health agency after the nation withdrew from being a member.
Drugs Health Medical

WHO director-general rebuts US criticism, plans to cut budget

Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, has given a four-point rebuttal to the US government’s accusations against the global.

Read More
Franco-Italian EssilorLuxottica SA got approval from the Food and Drug Administration to market its over-the-counter audio glasses in the US for people with hearing loss.
Health Medical Pharma

EssilorLuxottica gets regulator nod for audio glasses in US, EU for hearing loss

Franco-Italian EssilorLuxottica SA got approval from the Food and Drug Administration to market its over-the-counter audio glasses in the US for people with.

Read More
AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish drugmaker.
Uncategorized

EU panel gives a positive opinion for AstraZeneca’s cancer drug

AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish.

Read More